Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma

被引:0
|
作者
Li, Guangyao [1 ]
Atiq, Warda [2 ]
Hashmi, Muhammad Furqan [3 ]
Ibrahim, Shebl Salah [4 ]
Abdulsalam, Kholoud Abdulrhman Al [5 ]
Kadham, Mustafa Jawad [6 ]
Al-Azzawi, Abdul Kareem J. [7 ]
Aufy, Mohammed [8 ]
Abdel-Maksoud, Mostafa A. [9 ,10 ]
机构
[1] Second Peoples Hosp Wuhu, Dept Gastrointestinal Surg, Wuhu, Anhui, Peoples R China
[2] Fatima Jinnah Med Univ, Lahore, Pakistan
[3] Sharif Med & Dent Coll, Lahore, Pakistan
[4] King Saud Univ, Dept Biochem, Riyadh, Saudi Arabia
[5] King Saud Univ, Coll Food & Agr Sci, Dept Food Sci & Nutr, Riyadh, Saudi Arabia
[6] Al Farahidi Univ, Coll Med Tech, Baghdad, Iraq
[7] Al Turath Univ Coll, Baghdad, Iraq
[8] Univ Vienna, Dept Pharmaceut Sci, Div Pharmacol & Toxicol, Vienna, Austria
[9] King Saud Univ, Coll Sci, Dept Bot & Microbiol, PO 2455, Riyadh 11451, Saudi Arabia
[10] King Saud Univ, Coll Sci, Dept Bot & Microbiol, PO 2455, Riyadh 11451, Saudi Arabia
来源
关键词
Lung adenocarcinoma; hub genes; biomarkers; chemotherapeutic drugs; EXPRESSION OMNIBUS; PROGNOSTIC-FACTORS; TISSUE INHIBITOR; BREAST-CANCER; SERUM-LEVELS; TUMOR; TIMP1; INTERLEUKIN-6; OSTEOPONTIN; CLASSIFICATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Lung adenocarcinoma (LUAD) is recognized as one of the most prevalent and deadliest malignancies around the globe. The molecular mechanisms behind LUAD have not been fully elucidated. This study was launched to explore LUAD-associated hub genes and their enriched pathways using bioinformatics methods. Methods: Information on GSE10072 was retrieved from the Gene Expression Omnibus (GEO) database and analyzed via the Limma package-based GEO2R tool to obtain the top 100 differentially expressed genes (DEGs) in LUAD. The protein-protein interaction (PPI) network of the DEGs was drawn using the STRING website and was shifted into Cytoscape to screen the top 6 hub genes via the CytoHubba application. Furthermore, the expression analysis and validation of hub genes in LUAD samples and cell lines were done using UALCAN, OncoDB, and GENT2 databases. Moreover, OncoDB was also used for analyzing hub gene DNA methylation levels. In addition, cBioPortal, GSEA tool, Kaplan-Meier (KM) plotter, Enrichr, CancerSEA, and DGIdb were performed to explore some other important aspects of hub genes in LUAD. Results: We identified Interleukin 6 (IL6), Collagen, type I, alpha 1 (COL1A1), TIMP metallopeptidase inhibitor 1 (TIMP1), CD34 molecule (CD34), Decorin (DCN), and Secreted Phosphoprotein 1 (SPP1) genes as the hub genes in LUAD, out of which IL6, CD34, and DCN were significantly down-regulated while COL1A1, TIMP1, and SPP1 were significantly up-regulated in LUAD cell lines and samples of diverse clinical variables. In this study, we also documented some important correlations between hub genes and other parameters such as DNA methylation, genetic alterations, Overall Survival (OS), and 14 important states at the single cell level. Lastly, we also identified hub genes associated with the ceRNA network and 11 important chemotherapeutic drugs. Conclusion: We identified 6 hub genes involved in the development and progression of LUAD. These hub genes can also be helpful in the accurate detection of LUAD and provide novel ideas for treatment.
引用
收藏
页码:1550 / 1568
页数:19
相关论文
共 50 条
  • [21] Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time
    Liu, Dan
    Yao, Lulu
    Ding, Xiaolei
    Zhou, Huan
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 164
  • [22] Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis
    Kikutake, Chie
    Yahara, Koji
    PLOS ONE, 2016, 11 (04):
  • [23] Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms
    Huang, Zhong
    Liang, Feifei
    Wu, Jiangtao
    Huang, Zichong
    Li, Yinglian
    Huang, Xiaoyuan
    Liu, Zhenyu
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [24] Joint multi-omics screening of neutrophil-related biomarkers for lung adenocarcinoma
    Li, Yunfeng
    Fei, Jie
    Yu, Hongyan
    Shen, Weiyu
    ONCOLOGIE, 2025, 27 (01) : 149 - 165
  • [25] Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An in silico Profiling for Precise Medicine
    Ruan, Xinjia
    Ye, Yuqing
    Cheng, Wenxuan
    Xu, Li
    Huang, Mengjia
    Chen, Yi
    Zhu, Junkai
    Lu, Xiaofan
    Yan, Fangrong
    FRONTIERS IN MEDICINE, 2022, 9
  • [26] Integrated Multi-Omics Landscape of Liver Metastases
    Yang, Shuai
    Qian, Ling
    Li, Zhixuan
    Li, Ye
    Bai, Jian
    Zheng, Bo
    Chen, Kun
    Qiu, Xinyao
    Cai, Guoxiang
    Wang, Shan
    Huang, Haiyan
    Wu, Jianmin
    Zhu, Yanjing
    Zhangyang, Qianwen
    Feng, Lanyun
    Wu, Tong
    Wu, Rui
    Yang, Airong
    Wang, Kaiting
    Wang, Ruiru
    Zhang, Yani
    Zhao, Yan
    Wang, Wenwen
    Bao, Jinxia
    Shen, Siyun
    Hu, Ji
    Wu, Xuan
    Zhou, Tao
    Meng, Zhiqiang
    Liu, Weiwei
    Wang, Hongyang
    Wang, Peng
    Chen, Lei
    GASTROENTEROLOGY, 2023, 164 (03) : 407 - 423.e17
  • [27] MULTI-OMICS LANDSCAPE OF PRECANCEROUS LIVER DISEASE
    Budzinska, M.
    Tu, T.
    Cheng, R.
    D'Avigdor, W.
    Shackel, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S570 - S570
  • [28] Advances in the multi-omics landscape of follicular lymphoma
    Xu, Tianyuan
    Zheng, Zhong
    Zhao, Weili
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (06): : 1955 - 1967
  • [29] Multi-omics identification of a signature based on malignant cell-associated ligand-receptor genes for lung adenocarcinoma
    Xu, Shengshan
    Chen, Xiguang
    Ying, Haoxuan
    Chen, Jiarong
    Ye, Min
    Lin, Zhichao
    Zhang, Xin
    Shen, Tao
    Li, Zumei
    Zheng, Youbin
    Zhang, Dongxi
    Ke, Yongwen
    Chen, Zhuowen
    Lu, Zhuming
    BMC CANCER, 2024, 24 (01)
  • [30] A model-free and distribution-free multi-omics integration approach for detecting novel lung adenocarcinoma genes
    Zhao, Shaofei
    Qi, Caleb
    Zhao, Geran
    Wang, Yangsheng
    Fu, Guifang
    SCIENTIFIC REPORTS, 2024, 14 (01):